Session Description
This session will highlight the impact of the global gag rule and the domestic (US) gag rule on women and girls in all their diversity. 
Session Description
This session will explore the politics of decriminalization as part of a structural response to HIV. It will outline the aspects of science and the criminalization of sex work, drug use and sexual and gender identity, diversity and orientation. The session will address the effects of criminalization in the response to HIV.
Session Description
This session will showcase evidence-based community-led HIV  programmes. While some people argue that community-led responses are necessary for effective and sustainable HIV programmes, some consider them as a "fantasy" imposed by donors or pushed by advocates. Research will shed light on the effectiveness, efficiency and impact of community-led responses.
Session Description
This session will highlight the importance of ensuring adequate financing and support for community-led responses to HIV, by illustrating examples of community-led programmes on financing approaches and challenges, including social contracting mechanisms.  
Session Description
This session will present data on the benefits of the intersection between sexuel pleasure, rights and health as part of  sex-positive approach. It will illustrate how this improves sexual and reproductive health and well-being, including HIV clinical practice and increases acceptance of sexual rights and sexual pleasure within the broader community.
Session Description
This session will delve into the policing of gender and sexual diversity and its connections to HIV programming and services. The session will bring attention to the detriments of criminal provisions on marginalized communities. Criminalization of non-normative positions (identities, expressions and choices about individuals’ bodies) continues to make already marginalized communities more vulnerable to further exclusion from HIV, sexual reproductive health and other health-related services.
Session Description
This session will examine the state of HIV cure research, including perspectives from scientists, ethicists and the community. It will provide a broad overview on data surrounding cure trials to date, provoke discussion on the ethics of cure trials and explore ways to enhance community engagement.
Session Description
The session will explore gender-affirming and gender-transformative approaches offering opportunities and tools to reach communities that are gender and sexually diverse in the global HIV response.
Session Description
Biomedical prevention strategies – particularly PrEP – are highly efficacious, but their impact is greatest so far in men who have sex with men. Women are seemingly falling behind with prevention options; a common narrative still exists that PrEP works less well in women and that women do not take PrEP. Strikingly, the newest PrEP option (oral emtricitabine/tenofovir alafenamide) was recently approved with an indication that explicitly excludes women. Together, this begs the question: Are women losing out when it comes to biomedical HIV prevention?
Session Description
This session will review the latest findings on important co-infections and co-morbidities with HIV infection, in particular TB, HIV cognitive disorder, HBV and HPV-related cancers.
Session Description
This session will explore advances in HIV-related implementation research methods. It will include real-world examples to showcase the utility of these methods in optimizing the impact of HIV prevention and treatment responses. Topics that will be covered include implementation strategies for marginalized communities, methods such as behavioural economics, and implementation case studies from diverse settings.
Session Description
This session will focus on methods and approaches to maximize the efficiency and impact of country-level and global HIV responses. It will explore ways to inform budget allocation decisions for HIV prevention and treatment.
Session Description
This session will explore how implementation of integrated comprehensive sexual and reproductive health and rights (SRHR) is necessary to address the complex issues in the life of women living with HIV. Women living with HIV continue to face barriers created by gender, status in society, race inequities,  isolation, gender-based violence and stigma. An integrated intervention using a gender analysis in the implementation of comprehensive SRHR and HIV programs shows the greatest impact individually, interpersonally, communally and socially for the lives of transgender,  black cis and other women globally.  
Session Description
People living with HIV can now live longer than ever before, but they experience unique challenges while ageing. This session will bring together experts from different disciplines – epidemiology, the community, the clinic and basic research – for in-depth dialogue about all aspects of ageing and living with HIV.
Session Description
The existence of the latent HIV reservoir is a major barrier to HIV remission. Understanding how the reservoir is established during HIV infection and maintained during antiretroviral therapy will guide the development of interventions to target the reservoir. This session will explore new data that inform our current understanding of the characteristics of the HIV reservoir in lymph nodes, the gut and the brain, and strategies to overcome barriers towards their elimination.
Session Description
HIV cure research has come a long way in recent years, and cutting-edge experimental approaches are currently being tested in clinical trials. This session will bring together international experts working on next-generation cure approaches involving advanced gene therapy and gene-editing technologies. It will include an overview of this fast-moving field and a panel discussion about the promise, safety and feasibility of these approaches, especially in resource-limited countries.
Session Description
This session is designed to highlight innovative interventions that have been implemented globally to address stigma on individual, societal, structural and policy levels. It will showcase that stigma towards a person living with HIV undermines access to diagnosis, treatment and successful health outcomes. 
Session Description
This session will cover the latest topics in antiretroviral therapy, including two-drug regimens, long acting therapy, weight gain and ART, ART in women (including pregnancy) and new antiretroviral agents.
Session Description
The session will focus on how to leverage advances in digital technology to improve scale and efficiencies in the HIV response by involving young people and young social influencers who are transforming the way of approaching HIV.
Session Description
This session will address the state of science on the relationship between HIV and the opioid epidemic in a global context. It will provide evidence of effective interventions to address HIV and opioid epidemics in Central Asia and Eastern Europe and implications for other regions. In addition, it will focus on the role of harm reduction interventions in reducing HIV and opioid use disorders.
Session Description
 Isolation can be a direct result of internalized stigma and, in turn, it impacts health and wellness as well as different forms of social participation including using health services and participating in community activities.  Three different experiences will illustrate how social empowerment is key to personal resilience. The impact of isolation in people’s lives will demonstrate the challenges of isolation as well as how experiences of building social capital helped people to thrive and improve their quality of life. 
Session Description
This session will address the HIV epidemic from an indigenous peoples' perspective and  highlight ways in which indigenous populations' organizations, HIV agencies and experts can collaborate together to increase their health and well-being  by lowering the disproportionate impact of HIV and AIDS on indigenous communities. 
Session Description
The session will provide insights into the dynamics of healthcare utilization/access by transgender  people. It will share experiences by transgender people, health workers and clinicians providing HIV services. It will also highlight interactions with individuals and health systems that do not lead to the best health outcomes. It will as well look at the development of trans-specific healthcare beyond HIV and the empowerment processes in building community trust to help to get there.  
Session Description
This session will assess the complexities of HIV prevention trial design in the era of effective PrEP and discuss alternative designs and analytic techniques to help guide the design of future prevention trials. Given the proven efficacy of oral PrEP, the design of studies to determine the efficacy of new prevention technologies has become more complex. This session will be a state-of-the-art update of  ongoing HIV prevention trials and new options coming soon into trials. It will explore theoretical and practical issues influencing trial design in an era when effective HIV prevention using oral PrEP is already widely available. This will include the use of different endpoints, new statistical analysis techniques, ethical considerations and practical issues of enrolling and randomizing patients in HIV prevention trials.
Session Description
This session will focus on HIV advocacy, its history, evolution and current challenges. Advocacy happens when a group of people unite and take action in response to disparity and inequity. HIV advocacy has a history of powerful effectiveness because it was a grassroots-driven response to a crisis.
Session Description
This session will address the need for governments to involve populations, communities and civil society in decision making processes. It will provide examples of effective mechanisms of social participation that empower vulnerable groups, make public policies more tailored to their needs and hold governments to account.
Session Description
This session will explore the experiences of migrants and HIV services. It will also analyse the evidence around the exclusion of migrants and internally displaced people from HIV programming.
Session Description
This session will incorporate five diverse perspectives on the intersections of diversity and engagement in HIV prevention and treatment services among young people.
Session Description
This session will showcase four case studies (Mexico, India, Kenya and Ukraine) and share their own community-driven research by sharing what have been learned from different methodologies, which tools work best and why they have been successful and what could have been done better.
Session Description
This session will highlight person-centred approaches that simplify and adapt service delivery across the HIV prevention and care continuum to reflect the needs and circumstances of people living with and vulnerable to HIV while reducing unnecessary burdens on them and the health system. It will use effective differentiated  service delivery models that demonstrate person-centred approaches across the HIV continuum and their focus population, outreach strategies, resources required, successful outcomes and potential for replication and scale up. 
Session Description
This session offers four perspectives on where we are and where we should go as we aim to end the HIV epidemic around the world. Speakers will take four distinct perspectives, each speaking across geographies and populations. 
Session Description
This session will focus on successful strategies for implementing people-centred PrEP. It will share some innovative strategies to retain people on PrEP, such as integration into existing services, specifically family planning and STIs clinics. 
Session Description
This session will provide an overview of people-centred integrated approaches that provide access to comprehensive services needed to prevent and treat co-occurring infections and conditions. It will provide an opportunity for participants to share best practices and strategies to develop integrated health programmes from three entry points: The criminal justice system, clinical care programmes and, community programmes and networks.  
Session Description
This session will review new formulations for HIV treatment and prevention and what systems are needed to implement them, as well as analyse experiences from other fields for different populations.
Session Description
This session will  discuss the  current PrEP cascade, providing a global perspective of PrEP retention among young men who have sex with men. The session will also showcase some innovative strategies to retain people on PrEP, such as integration into existing services, specifically family planning and STI clinics.
Session Description
This session will provoke discussion on the various modes and structures that contribute to HIV-related stigma and discrimination. It will share information that will empower communities and enhances individual and community efforts to increase awareness of U=U as one strategy to address stigma and discrimination.
Session Description
This session will address the worsening global epidemic of STIs and the interface with the expansion of HIV treatment and prevention, including emerging strategies in diagnosis and prevention. Exciting new research in STI testing, treatment, partner treatment and prevention relevant globally will be highlighted. It will also include a debate on whether to use doxycycline post-exposure prophylaxis for STI prevention, and the benefits and potential risks. 
Session Description
This session will focus on the HIV response in the context of Universal Health Coverage (UHC) and the Sustainable Development Goals (SDG). Some people view the UHC and SDG agenda with the “leave no one behind” principle, as a great opportunity for the HIV response and HIV-affected populations. Others are more cautious or even consider the agenda as a threat to the HIV response. Nevertheless, UHC is rolling out, as is SDG 3 and other SDGs. What does the HIV response offer and how do we make use of that for the realization of UHC and SDGs? What opportunities can the UHC and SDGs agenda bring to the HIV response and affected key populations? This session will review different countries’ experiences, civil society reflection and analysis from agenda setters to come up with observations and/or conclusions about the place of HIV in UHC and the SDGs and how to make the best of it.
Session Description
This session will examine the current situation of women living with HIV across the globe through the lens of data requirements and gaps; and leadership advances. It will highlight those programmes and strategies which can be replicated for greater impact.